undamentalytics Newsletter
Sign in

Inogen Inc cash flow statement

In fiscal 2025, Inogen Inc's operations generated −$11.2m of cash; it spent $2.5m on capital projects, leaving free cash flow of −$13.7m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations4131638316060413724−38−36−11−3
Depreciation and amortisation5912141412111419222418212117
Stock-based pay0014710139811127787
Capital spending232223834535332
Free cash flow2101436295852373318−41−83−14−5
Free cash flow after stock pay210133222483928247−53−16−5−22−12
Shares issued—————————————27—

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: INGN vs TCMDINGN vs STAAINGN vs INMDINGN vs PRCT

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Inogen Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Inogen Inc.